Cargando…
Heparan Sulfate Proteoglycans in Infection
To cause infections, microbial pathogens elaborate a multitude of factors that interact with host components. Using these host–pathogen interactions to their advantage, pathogens attach, invade, disseminate, and evade host defense mechanisms to promote their survival in the hostile host environment....
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120983/ http://dx.doi.org/10.1007/978-3-642-16833-8_2 |
_version_ | 1783515097632604160 |
---|---|
author | Bartlett, Allison H. Park, Pyong Woo |
author_facet | Bartlett, Allison H. Park, Pyong Woo |
author_sort | Bartlett, Allison H. |
collection | PubMed |
description | To cause infections, microbial pathogens elaborate a multitude of factors that interact with host components. Using these host–pathogen interactions to their advantage, pathogens attach, invade, disseminate, and evade host defense mechanisms to promote their survival in the hostile host environment. Many viruses, bacteria, and parasites express adhesins that bind to cell surface heparan sulfate proteoglycans (HSPGs) to facilitate their initial attachment and subsequent cellular entry. Some pathogens also secrete virulence factors that modify HSPG expression. HSPGs are ubiquitously expressed on the cell surface of adherent cells and in the extracellular matrix. HSPGs are composed of one or several heparan sulfate (HS) glycosaminoglycan chains attached covalently to specific core proteins. For most intracellular pathogens, cell surface HSPGs serve as a scaffold that facilitates the interaction of microbes with secondary receptors that mediate host cell entry. Consistent with this mechanism, addition of HS or its pharmaceutical functional mimic, heparin, inhibits microbial attachment and entry into cultured host cells, and HS-binding pathogens can no longer attach or enter cultured host cells whose HS expression has been reduced by enzymatic treatment or chemical mutagenesis. In pathogens where the specific HS adhesin has been identified, mutant strains lacking HS adhesins are viable and show normal growth rates, suggesting that the capacity to interact with HSPGs is strictly a virulence activity. The goal of this chapter is to provide a mechanistic overview of our current understanding of how certain microbial pathogens subvert HSPGs to promote their infection, using specific HSPG–pathogen interactions as representative examples. |
format | Online Article Text |
id | pubmed-7120983 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
record_format | MEDLINE/PubMed |
spelling | pubmed-71209832020-04-06 Heparan Sulfate Proteoglycans in Infection Bartlett, Allison H. Park, Pyong Woo Glycans in Diseases and Therapeutics Article To cause infections, microbial pathogens elaborate a multitude of factors that interact with host components. Using these host–pathogen interactions to their advantage, pathogens attach, invade, disseminate, and evade host defense mechanisms to promote their survival in the hostile host environment. Many viruses, bacteria, and parasites express adhesins that bind to cell surface heparan sulfate proteoglycans (HSPGs) to facilitate their initial attachment and subsequent cellular entry. Some pathogens also secrete virulence factors that modify HSPG expression. HSPGs are ubiquitously expressed on the cell surface of adherent cells and in the extracellular matrix. HSPGs are composed of one or several heparan sulfate (HS) glycosaminoglycan chains attached covalently to specific core proteins. For most intracellular pathogens, cell surface HSPGs serve as a scaffold that facilitates the interaction of microbes with secondary receptors that mediate host cell entry. Consistent with this mechanism, addition of HS or its pharmaceutical functional mimic, heparin, inhibits microbial attachment and entry into cultured host cells, and HS-binding pathogens can no longer attach or enter cultured host cells whose HS expression has been reduced by enzymatic treatment or chemical mutagenesis. In pathogens where the specific HS adhesin has been identified, mutant strains lacking HS adhesins are viable and show normal growth rates, suggesting that the capacity to interact with HSPGs is strictly a virulence activity. The goal of this chapter is to provide a mechanistic overview of our current understanding of how certain microbial pathogens subvert HSPGs to promote their infection, using specific HSPG–pathogen interactions as representative examples. 2011-03-19 /pmc/articles/PMC7120983/ http://dx.doi.org/10.1007/978-3-642-16833-8_2 Text en © Springer-Verlag Berlin Heidelberg 2011 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Bartlett, Allison H. Park, Pyong Woo Heparan Sulfate Proteoglycans in Infection |
title | Heparan Sulfate Proteoglycans in Infection |
title_full | Heparan Sulfate Proteoglycans in Infection |
title_fullStr | Heparan Sulfate Proteoglycans in Infection |
title_full_unstemmed | Heparan Sulfate Proteoglycans in Infection |
title_short | Heparan Sulfate Proteoglycans in Infection |
title_sort | heparan sulfate proteoglycans in infection |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120983/ http://dx.doi.org/10.1007/978-3-642-16833-8_2 |
work_keys_str_mv | AT bartlettallisonh heparansulfateproteoglycansininfection AT parkpyongwoo heparansulfateproteoglycansininfection |